文献速递类风湿关节炎其他结缔组织病

类风湿关节炎相关肺病在临床胸部CT中的患病率、危险因素及对死亡率的影响

Rheumatoid arthritis-related lung disease detected on clinical chest computed tomography imaging: Prevalence, risk factors, and impact on mortality.
PubMed 文献 · Semin Arthritis Rheum · 2020-09-28

本研究回顾性分析190例因临床指征行胸部CT的类风湿关节炎(RA)患者,28.4%检出RA相关肺病,包括间质性肺病(ILD)15.8%、支气管扩张14.2%和胸膜病变9.5%。男性及当前使用甲氨蝶呤与RA相关肺病相关,RA相关肺病患者随访期间死亡率高,但校正后死亡风险置信区间宽。

要点

  • 临床胸部CT中28.4%的RA患者检出RA相关肺病,血清阳性与阴性无差异。
  • 男性(OR 2.62)和当前使用甲氨蝶呤(OR 2.73)与RA相关肺病相关。
  • RA相关肺病患者随访期间44.4%死亡,需密切监测。

核心结论

  • 在真实世界临床胸部CT中,RA相关肺病常见且与RA血清状态无关。
  • RA相关肺病患者死亡率高,强调密切监测的重要性。

研究设计与样本

  • 回顾性研究分析190例因临床指征行胸部CT的RA患者,平均年龄64.2岁(SD 11.8),女性80.0%,血清阳性75.3%。
  • RA相关肺病定义为间质性肺病(ILD)、支气管扩张或胸膜病变,依据胸部CT影像报告判断。
  • 采用logistic回归分析危险因素,生存曲线和Cox回归分析死亡率。

主要发现

  • 54例(28.4%)检出RA相关肺病,其中ILD 30例(15.8%)、支气管扩张27例(14.2%)、胸膜病变18例(9.5%)。
  • 血清阳性与血清阴性RA中RA相关肺病比例分别为28.7%和27.7%(p=1.00)。
  • 男性(OR 2.62,95%CI 1.17-5.88)和当前使用甲氨蝶呤(OR 2.73,95%CI 1.27-5.61)与RA相关肺病相关。
  • RA相关肺病对比正常胸部CT的死亡风险HR为5.35(95%CI 0.72-39.9)。

临床怎么用

  • 对RA患者应关注临床胸部CT所见的肺病,不因血清阴性而忽视。
  • 男性和当前使用甲氨蝶呤的RA患者应警惕RA相关肺病风险。
  • 检出RA相关肺病后需密切监测,因其与高死亡率相关。

局限性

  • 研究为单中心回顾性设计,样本量190例,仅纳入因临床指征行胸部CT的患者,可能存在选择偏倚。
  • 死亡风险HR的95%CI宽(0.72-39.9),提示估计不精确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We aimed to determine the real-world prevalence and investigate risk factors for rheumatoid arthritis (RA)-related lung disease on chest computed tomography (CT) imaging. We also investigated the impact of RA-related lung disease on mortality. METHODS: We studied chest CT imaging abnormalities among RA patients. We determined the presence and type of abnormalities using the chest CT imaging radiologic report. RA-related lung disease was defined as interstitial lung disease (ILD), bronchiectasis, or pleural disease. We examined whether demographics and RA characteristics were associated with RA-related lung disease using logistic regression. RA-related lung disease and mortality was described using survival curves and Cox regression. RESULTS: We analyzed 190 patients who had chest CT imaging performed for clinical indications. Mean age was 64.2 years (SD 11.8), 80.0% were female, and 75.3% were seropositive. RA-related lung disease was detected in 54 patients (28.4%); 30 (15.8%) had ILD, 27 (14.2%) had bronchiectasis, and 18 (9.5%) had pleural disease. RA-related lung disease was reported in both seropositive and seronegative RA (28.7% vs. 27.7%, p = 1.00). Male sex (OR 2.62, 95%CI 1.17-5.88) and current methotrexate use (OR 2.73, 95%CI 1.27-5.61 vs. not current) were associated with RA-related lung disease. Twenty-four (44.4%) patients with RA-related lung disease died during mean 7.0 years of follow-up. RA-related lung disease had HR of 5.35 (95%CI 0.72-39.9) for mortality compared to normal chest CT. CONCLUSIONS: In this real-world study, RA-related lung disease was commonly detected on chest CT imaging regardless of RA serostatus. RA-related lung disease had high mortality, emphasizing the importance in close monitoring of these patients.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Huang S, Doyle TJ, Hammer MM, et al. Rheumatoid arthritis-related lung disease detected on clinical chest computed tomography imaging: Prevalence, risk factors, and impact on mortality. Semin Arthritis Rheum. 2020. PMID: 33059295. doi:10.1016/j.semarthrit.2020.08.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。